Atrial fibrillation burden: a new outcome predictor and therapeutic target
N Becher, A Metzner, T Toennis, P Kirchhof… - European Heart …, 2024 - academic.oup.com
Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is not a dichotomous
disease trait. Technological innovations enable long-term rhythm monitoring in many …
disease trait. Technological innovations enable long-term rhythm monitoring in many …
Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the …
G Ntaios, H Baumgartner, W Doehner… - European Heart …, 2024 - academic.oup.com
One in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS),
defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The …
defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The …
Anticoagulation in patients with device‐detected atrial fibrillation with and without a prior stroke or transient ischemic attack: the NOAH‐AFNET 6 trial
HC Diener, N Becher, S Sehner, T Toennis… - Journal of the …, 2024 - ahajournals.org
Background Short and rare episodes of atrial fibrillation (AF) are commonly detected using
implanted devices (device‐detected AF) in patients with prior stroke or transient ischemic …
implanted devices (device‐detected AF) in patients with prior stroke or transient ischemic …
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Aims Recent trial data demonstrate beneficial effects of active rhythm management in
patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is …
patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is …
Innovative approaches to atrial fibrillation prediction: should polygenic scores and machine learning be implemented in clinical practice?
AM Petzl, G Jabbour, J Cadrin-Tourigny… - Europace, 2024 - academic.oup.com
Atrial fibrillation (AF) prediction and screening are of important clinical interest because of
the potential to prevent serious adverse events. Devices capable of detecting short episodes …
the potential to prevent serious adverse events. Devices capable of detecting short episodes …
Atrial cardiopathy biomarkers and atrial fibrillation in the ARCADIA trial
H Kamel, MSV Elkind, RA Kronmal… - European Stroke …, 2024 - journals.sagepub.com
Background: ARCADIA compared apixaban to aspirin for secondary stroke prevention in
patients with cryptogenic stroke and atrial cardiopathy. One possible explanation for the …
patients with cryptogenic stroke and atrial cardiopathy. One possible explanation for the …
Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial
Importance Approximately 10% to 15% of ischemic strokes are associated with cancer;
cancer-associated stroke, particularly when cryptogenic, is associated with high rates of …
cancer-associated stroke, particularly when cryptogenic, is associated with high rates of …
Role of Cardiac Biomarkers in Stroke and Cognitive Impairment
MC Johansen, R Von Rennenberg, CH Nolte… - Stroke, 2024 - ahajournals.org
This topical review assesses the growing role of cardiac biomarkers beyond cardiovascular
health and focuses on their importance in stroke and dementia. The first part describes …
health and focuses on their importance in stroke and dementia. The first part describes …
[HTML][HTML] Cardioembolic Stroke: Past Advancements, Current Challenges, and Future Directions
Y Kato, K Tsutsui, S Nakano, T Hayashi… - International Journal of …, 2024 - mdpi.com
Cardioembolic stroke accounts for over 20% of ischemic strokes and is associated with
worse outcomes than other types of strokes. Atrial fibrillation (AF) is the most common risk …
worse outcomes than other types of strokes. Atrial fibrillation (AF) is the most common risk …
Thromboembolic and Bleeding Risk in Cardiac Amyloidosis
Cardiac amyloidosis represents a spectrum of conditions characterized by the accumulation
of insoluble fibrils, resulting in progressive deposition and myocardial dysfunction. The exact …
of insoluble fibrils, resulting in progressive deposition and myocardial dysfunction. The exact …